Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Cardiovascular Medicine›Stroke
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Stroke

Cardiovascular Medicine · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 6 min read

A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to brain ischemia or intracranial hemorrhages.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (1,150 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to brain ischemia or intracranial hemorrhages. Stroke is classified by the type of tissue necrosis, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Strokes; Cerebrovascular Accident; Cerebrovascular Accidents; Cerebral Stroke; Cerebral Strokes; Stroke, Cerebral; Strokes, Cerebral; Cerebrovascular Apoplexy.

Where it fits in the MeSH classification

Broader topics
Cerebrovascular Disorders
Narrower topics
Brain Infarction; Hemorrhagic Stroke; Ischemic Stroke

Related concepts

  • Brain Ischemia
  • Intracranial Hemorrhages
  • Necrosis

Research landscape

PubMed indexes 205,650 records tagged with the MeSH heading “Stroke” (counts retrieved 2026-10-29). 71,137 of them (34.6%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 78,964 records.

Reviews account for 32,714 records (15.9%) and meta-analyses for 7,383. Randomized controlled trials number 10,374 (5.0%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 11,983 records; 2000-2009: 43,566 records; 2010-2019: 78,964 records; 2020 onward: 71,137 records11,983through 199943,5662000-200978,9642010-201971,1372020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199911,983
2000-200943,566
2010-201978,964
2020 onward71,137
Share of records by publication typeReviews: 15.9 percent; Meta-analyses: 3.6 percent; Randomized controlled trials: 5.0 percentReviews15.9% (32,714)Meta-analyses3.6% (7,383)Randomized controlled trials5.0% (10,374)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 205,650 PubMed records
TypeRecordsShare
Reviews32,71415.9%
Meta-analyses7,3833.6%
Randomized controlled trials10,3745.0%

Method: PubMed query "Stroke"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in cardiovascular medicine

Cardiovascular medicine has an unusually large body of randomized trials, so the type of outcome matters: hard clinical events such as death, heart attack and stroke carry more weight than changes in blood pressure, cholesterol or imaging markers that only predict risk. Observational studies can show associations but are confounded by age, lifestyle and other illness. Check whether a result is about prevention or treatment, the baseline risk of participants, and the absolute rather than only the relative size of any benefit.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
TMS-Derived Neurophysiological Measures of Corticospinal Excitability, Intracortical Excitability, and Interhemispheric Interactions Associated With Post-Stroke Motor Recovery: A Systematic Review
Pereira GS, da Silva ML, Baptista AF, de Araujo JE
2026Systematic review
Design not recorded in structured metadata
1cc by
PMID 42830194 · DOI · PMC13634656
Implementing Evidence-Based Somatosensory Rehabilitation After Stroke: Reported Practice, Documented Practice, and Barriers
Joy A, Harding KE, Carey LM
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42742364 · DOI · PMC13576632
Acid-sensing ion channels in ischemic stroke: amplifying and constraining neuronal injury in a phase-specific framework
Weng OY, Lu JF, Qi X, Chen X, Wang LY, Xu TL
2026Review article
Design not recorded in structured metadata
0cc by
PMID 42850478 · DOI · PMC13649881
Ambient particulate matter pollution and stroke burden
Jiang L, Yu K, Gu L, Xiao W, Tan W, Jiang Y, et al.
2027Research article
Design not recorded in structured metadata
0cc by
PMID 42734442 · DOI · PMC13667390

TMS-Derived Neurophysiological Measures of Corticospinal Excitability, Intracortical Excitability, and Interhemispheric Interactions Associated With Post-Stroke Motor Recovery: A Systematic Review [1]

Systematic review Pereira GS, da Silva ML, Baptista AF, de Araujo JE · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Motor recovery after stroke is associated with changes in corticospinal integrity, intracortical excitability, and interhemispheric interactions.
Closing excerpt
Standardized TMS protocols are needed to clarify their monitoring, prognostic, and treatment-response value.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (324 words)

Motor recovery after stroke is associated with changes in corticospinal integrity, intracortical excitability, and interhemispheric interactions. Transcranial magnetic stimulation (TMS) provides neurophysiological measures of these processes, but their relationship with motor recovery across randomized controlled trials remains uncertain. This systematic review synthesized evidence from randomized controlled trials investigating TMS-derived neurophysiological measures associated with motor recovery following TMS-based neuromodulation after stroke. PubMed/MEDLINE, Scopus, and Embase were searched for studies published between January 1, 2016, and July 10, 2026. Eligible trials enrolled adults with ischemic or hemorrhagic stroke, assessed at least one TMS-derived neurophysiological measure, and reported a motor or functional outcome. Study selection followed PRISMA 2020, risk of bias was assessed using Cochrane RoB 2, and certainty of evidence was evaluated using GRADE. Owing to methodological heterogeneity, findings were synthesized narratively. The search identified 1441 records; after removal of 519 duplicates, 922 records were screened, 55 full-text reports were assessed, and 16 randomized controlled trials were included. Motor evoked potential (MEP) amplitude, MEP status, and resting motor threshold were the most frequently reported measures. Several trials found that changes in corticospinal excitability accompanied improvements in upper-limb function, activities of daily living, gait, or balance. One trial found greater motor gains among participants with preserved baseline MEPs; however, the contemporary randomized-trial evidence is insufficient to establish MEP status as a predictor of differential response to neuromodulation. In contrast, short-interval intracortical inhibition, cortical silent period, and interhemispheric inhibition were assessed in very few trials, whereas intracortical facilitation was not directly evaluated in any eligible RCT. Most studies raised some risk-of-bias concerns, and one study had high overall risk. Certainty was moderate for clinical motor recovery, low for MEP- and motor-threshold-based measures, and very low for intracortical and interhemispheric measures. Overall, MEP-derived measures and resting motor threshold were the most frequently reported neurophysiological domains, whereas baseline MEP status was evaluated in only one stratified trial. Standardized TMS protocols are needed to clarify their monitoring, prognostic, and treatment-response value.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42830194 · DOI · PMC13634656

Implementing Evidence-Based Somatosensory Rehabilitation After Stroke: Reported Practice, Documented Practice, and Barriers [2]

Research article Joy A, Harding KE, Carey LM · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionOccupational therapists play a key role in assessing and treating somatosensory impairments post stroke including proprioception (limb position sense), touch, and temperature discrimination.
Closing excerpt
Medical record audits aligned with survey findings; however, there were differences between reported and documented use and scope of sensory assessment and treatment in practice.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (291 words)

IntroductionOccupational therapists play a key role in assessing and treating somatosensory impairments post stroke including proprioception (limb position sense), touch, and temperature discrimination. Although research evidence and clinical guidelines offer strategies for assessing and treating this condition, there is limited information on how well these strategies are being implemented in routine practice. We aimed to describe the current practice of occupational therapists in somatosensory assessment and treatment of the upper limb of stroke survivors and to understand barriers and enablers to evidence-based care.MethodsThis observational study encompassed (1) a cross-sectional survey measuring self-reported use of somatosensory assessment and treatment strategies and perceived barriers to implementation and (2) a medical file audit to report on the use of somatosensory assessment and treatment with stroke patients. Data were analyzed descriptively, with enablers and barriers to evidence use classified using the three domains of the Capability, Opportunity, Motivation-Behavior (COM-B) change model.ResultsOf 50 files audited, 26 patients had documented upper limb impairment. Of these, 54% had sensation assessed. Treatment strategies were documented for 7 out of 12 patients with identified impairment. These findings aligned with therapist self-report, indicating that most clinicians used sensory assessment and treatment strategies less than once per month. Therapists reported capability (lack of skills and skill confidence) and opportunity (lack of time and opportunity to practice skills) as barriers to evidence-based practice. Occupational therapists expressed motivation to change and improve their skills in evidence-based sensory assessment and treatment.ConclusionOur findings highlight ongoing gaps between evidence and practice. Therapists report being motivated to provide evidence-based care but require support to overcome barriers, such as training and access to resources. Medical record audits aligned with survey findings; however, there were differences between reported and documented use and scope of sensory assessment and treatment in practice.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42742364 · DOI · PMC13576632

Acid-sensing ion channels in ischemic stroke: amplifying and constraining neuronal injury in a phase-specific framework [3]

Review article Weng OY, Lu JF, Qi X, Chen X, Wang LY, Xu TL · · 2026

Abstract reading summary — source excerpts
Opening excerpt
For decades, ischemic neuronal death was understood largely as a story about glutamate.
Closing excerpt
The question in ASIC-targeted neuroprotection is not only whether to inhibit the channel, but also when and for how long.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (245 words)

For decades, ischemic neuronal death was understood largely as a story about glutamate. Acid-sensing ion channels (ASICs) have revised that account. When cerebral blood flow stops, the penumbra can develop prolonged extracellular acidosis, and experimental studies implicate ASIC1a in mediating sufficient Ca²⁺ entry to injure neurons even when glutamate receptors are blocked, a contribution shaped by channel expression, subunit composition, and the intracellular signaling context. However, sustained acidosis does not necessarily imply sustained channel opening, given ASIC1a desensitization. Besides acidosis, glutamate, polyamines, a paradoxical intracellular alkalization, and oxidative stress can enhance ASIC1a activity or expression, and the channel also signals through a non-conducting route, recruiting RIPK1 to trigger necroptosis independently of ion flux. The relative contributions of these conducting and non-conducting mechanisms in vivo remain incompletely defined. Endogenous mechanisms may constrain injury by internalizing the channel, altering subunit expression, including conditioning-associated ASIC2a upregulation, and degrading ASIC1a through estrogen signaling. We argue that these responses are better understood as constraints on injury than as a genuine survival program, a distinction with mechanistic and therapeutic consequences. Critically, the contribution of these mechanisms may vary over time. The same channel acts as a target of homeostatic regulation before stroke, a driver of death during ischemia, a potential target at reperfusion when acidosis persists but restored flow finally permits drug delivery, and an impediment to repair for weeks afterward. The question in ASIC-targeted neuroprotection is not only whether to inhibit the channel, but also when and for how long.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42850478 · DOI · PMC13649881

Ambient particulate matter pollution and stroke burden [4]

Research article Jiang L, Yu K, Gu L, Xiao W, Tan W, Jiang Y, et al. · · 2027

Abstract reading summary — source excerpts
Opening excerpt
As a major component of air pollution, ambient particulate matter pollution has rarely been studied with respect to its global stroke burden.
Closing excerpt
For ongoing and future research efforts, priority should be given to high-risk populations and regions, while also developing innovative interventions to further reduce the incidence of ambient particulate matter pollution-related stroke and enhance patient outcomes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (290 words)

As a major component of air pollution, ambient particulate matter pollution has rarely been studied with respect to its global stroke burden. This study aims to evaluate the global stroke incidence, mortality, and health inequalities related to ambient particulate matter pollution from 1990 to 2021. Utilizing the Global Burden of Disease Study 2021, we analyzed global stroke-related mortality, disability-adjusted life years, and their age-standardized rates. The estimated annual percentage change was calculated using a linear regression model. Health inequalities were measured using the concentration index and slope index of inequality. Between 1990 and 2021, global ambient particulate matter pollution-related stroke deaths and disability-adjusted life years increased by 107% and 101% respectively, yet age-standardized rates declined. China experienced the largest increases in deaths and disability-adjusted life years, Vietnam had the fastest rise in age-standardized mortality rates, the Russian Federation saw the steepest declines in deaths and disability-adjusted life years, and Estonia had the most rapid drop in age-standardized mortality rate. Middle socio-demographic index locations accounted for 46% of the global stroke burden, with age-standardized mortality rates and age-standardized disability-adjusted life years surpassing those in high socio-demographic index locations. From 1990 to 2021, age-standardized disability-adjusted life years rose in low-middle socio-demographic index locations but fell in high socio-demographic index locations. While the concentration index signaled an improvement in global inequality, the slope index of inequality in 2021 worsened compared with that in 1990. Between 1990 and 2021, the global burden of ambient particulate matter pollution-related stroke declined. However, substantial disparities persisted across different regions, sexes, and nations. For ongoing and future research efforts, priority should be given to high-risk populations and regions, while also developing innovative interventions to further reduce the incidence of ambient particulate matter pollution-related stroke and enhance patient outcomes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42734442 · DOI · PMC13667390

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Can oral anticoagulants be safely discontinued after atrial fibrillation ablation? A systematic review and meta-analysis of reconstructed time-to-event data [5]
    Barbosa LM, Oliveira VMR, Rivera A, Araújo B, Cabral DCBI, Consoli LN, et al. · Heart Rhythm · 2026 · cited 11 times (Europe PMC)
  • Research article Comparison of the predictive performance of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio for three-month poor functional outcome in ischemic stroke: a systematic review and meta-analysis [6]
    Ma X, Zhou Y, Li Z, Mao G, Wei H, Zhao T · Ann Med · 2026 · cited 9 times (Europe PMC)
  • Research article Thrombectomy for Distal Medium Vessel Occlusion: A Meta-Analysis of Randomized Controlled Trials [7]
    Jhou HJ, Wang WS, Lee CH, Yang LY, Chen PH · J Am Heart Assoc · 2025 · cited 8 times (Europe PMC)
  • Research article Efficacy of Brain-Computer Interface Therapy for Upper Limb Rehabilitation in Chronic Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials [8]
    Chen H, Yun G · J Med Internet Res · 2026 · cited 7 times (Europe PMC)
  • Research article Bridging or Direct Thrombectomy in Posterior Circulation Large-Vessel Occlusion Stroke: Analysis of Binational Registries and Meta-Analysis [9]
    Chen CH, Kim YS, Lee CW, Chai CL, Hsieh YC, Park JM, et al. · Neurology · 2025 · cited 7 times (Europe PMC)
  • Research article Safety Outcomes Following Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review and Network Meta-analysis [10]
    Yao X, Ma K, Zhao B, He A, Sun W, Gao J, et al. · CNS Drugs · 2026 · cited 7 times (Europe PMC)

References

  1. Pereira GS, da Silva ML, Baptista AF, de Araujo JE. TMS-Derived Neurophysiological Measures of Corticospinal Excitability, Intracortical Excitability, and Interhemispheric Interactions Associated With Post-Stroke Motor Recovery: A Systematic Review. . 2026. PMID 42830194 · DOI · PMC13634656
  2. Joy A, Harding KE, Carey LM. Implementing Evidence-Based Somatosensory Rehabilitation After Stroke: Reported Practice, Documented Practice, and Barriers. . 2026. PMID 42742364 · DOI · PMC13576632
  3. Weng OY, Lu JF, Qi X, Chen X, Wang LY, Xu TL. Acid-sensing ion channels in ischemic stroke: amplifying and constraining neuronal injury in a phase-specific framework. . 2026. PMID 42850478 · DOI · PMC13649881
  4. Jiang L, Yu K, Gu L, Xiao W, Tan W, Jiang Y, et al.. Ambient particulate matter pollution and stroke burden. . 2027. PMID 42734442 · DOI · PMC13667390
  5. Barbosa LM, Oliveira VMR, Rivera A, Araújo B, Cabral DCBI, Consoli LN, et al.. Can oral anticoagulants be safely discontinued after atrial fibrillation ablation? A systematic review and meta-analysis of reconstructed time-to-event data. Heart Rhythm. 2026. PMID 41513055 · DOI
  6. Ma X, Zhou Y, Li Z, Mao G, Wei H, Zhao T. Comparison of the predictive performance of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio for three-month poor functional outcome in ischemic stroke: a systematic review and meta-analysis. Ann Med. 2026. PMID 41527423 · DOI · PMC12802519
  7. Jhou HJ, Wang WS, Lee CH, Yang LY, Chen PH. Thrombectomy for Distal Medium Vessel Occlusion: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2025. PMID 41065278 · DOI · PMC12684530
  8. Chen H, Yun G. Efficacy of Brain-Computer Interface Therapy for Upper Limb Rehabilitation in Chronic Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Med Internet Res. 2026. PMID 41605490 · DOI · PMC12895162
  9. Chen CH, Kim YS, Lee CW, Chai CL, Hsieh YC, Park JM, et al.. Bridging or Direct Thrombectomy in Posterior Circulation Large-Vessel Occlusion Stroke: Analysis of Binational Registries and Meta-Analysis. Neurology. 2025. PMID 41252660 · DOI
  10. Yao X, Ma K, Zhao B, He A, Sun W, Gao J, et al.. Safety Outcomes Following Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review and Network Meta-analysis. CNS Drugs. 2026. PMID 41026449 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Cerebrovascular DisordersCardiovascular Medicine
  • Ischemic StrokeCardiovascular Medicine
  • Intracranial AneurysmCardiovascular Medicine
  • Brain IschemiaCardiovascular Medicine
  • Hemorrhagic StrokeCardiovascular Medicine
  • Embolic StrokeCardiovascular Medicine

All 105 articles in Cardiovascular Medicine →

At a glance

205,650
PubMed records on this heading
35%
published since 2020
32,714
review articles
10,374
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Cerebrovascular DisordersCardiovascular Medicine
  • Ischemic StrokeCardiovascular Medicine
  • Intracranial AneurysmCardiovascular Medicine
  • Brain IschemiaCardiovascular Medicine
  • Hemorrhagic StrokeCardiovascular Medicine

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support